[Prognostic, diagnostic, and therapeutic prospects of using adiponectine as a biomarker in cardiobascular diseases].
The role of adipose tissue as an important endocrine organ is today beyond doubt. The adipose tissue is known to be a source of many biologically active substances, adipocitokines, one of them being the adiponectine possessing anti-inflammatory, antiatherogenic and cardioprotective properties; it is believed to be one of prospective biomarkers for risk assessment, for diagnostics and, possibly, for therapy of cardiovascular diseases.
Pal'tseva
E M
EM
Rodina
A V
AV
Konstantinova
S V
SV
Ermakov
N V
NV
Andreev
D A
DA
Syrkin
A L
AL
Severin
S E
SE
D052242:Adiponectin / Q000378:metabolism; D000273:Adipose Tissue / Q000378:metabolism*; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000378:metabolism; D015415:Biomarkers / Q000378:metabolism; D002316:Cardiotonic Agents / Q000378:metabolism; D002318:Cardiovascular Diseases / Q000175:diagnosis* / Q000378:metabolism*; D004702:Endocrine Glands / Q000473:pathology*; D006801:Humans; D011379:Prognosis
C499918:ADIPOQ protein, human; D052242:Adiponectin; D000893:Anti-Inflammatory Agents; D015415:Biomarkers; D002316:Cardiotonic Agents